Shabbir Dahod-Led TraceLink Raises $93 Million to Accelerate Expansion of Information-Sharing Network Platform Across Life Sciences

0
411
Shabbir Dahod (Photo: TraceLink website)

NORTH READING, MA–TraceLink Inc., a track and trace network for connecting the life sciences supply chain and providing real-time information sharing for better patient outcomes, closed a $93 million investment round led by Georgian Partners, with new investors Vulcan Capital and Willett Advisors LLC, and participation by all existing investors: FirstMark Capital, Volition Capital, F-Prime Capital and Goldman Sachs.

TraceLink also announced that Tyson Baber from Georgian Partners has joined its Board of Directors. Since its founding in 2009, TraceLink has attracted a total of $167 million in investments.

“As we continue to execute on our vision to build the digital supply chain, we are making strategic investments in machine learning, artificial intelligence and blockchain, ultimately delivering an open development platform for information sharing and predictive analytics,” said Shabbir Dahod, president and CEO, TraceLink. “Georgian Partners’ deep expertise will significantly aid our efforts in bringing global information-sharing applications to market, driving the entire industry forward to solve critical business challenges through supply chain digitalization.”

Tyson Baber, Partner, Georgian Partners, commented, “The pharmaceutical industry is at a digital tipping point and TraceLink is in the ideal position to drive major advancements in this transformation with its information-sharing network platform. We are very excited to partner with TraceLink on its next phase of growth and look forward to helping guide the company on its journey to shape the future of the digital drug supply network, leveraging our experience and clients’ collective expertise in artificial intelligence and machine learning.”

TraceLink’s network connects over 270,000 pharmaceutical companies, CMOs, wholesale distributors, 3PLs, parallel importers, repackagers, hospitals and pharmacies worldwide.

LEAVE A REPLY

Please enter your comment!
Please enter your name here